Immunogenicity of recombinant vaccinia viruses that display the HIV type 1 envelope glycoprotein on the surface of infectious virions.

R Blasco, B Moss, Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein. Journal of Virology. ,vol. 65, pp. 5910- 5920 ,(1991) , 10.1128/JVI.65.11.5910-5920.1991

A A McIntosh, G L Smith, Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. Journal of Virology. ,vol. 70, pp. 272- 281 ,(1996) , 10.1128/JVI.70.1.272-281.1996

P L Earl, A W Hügin, B Moss, Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. Journal of Virology. ,vol. 64, pp. 2448- 2451 ,(1990) , 10.1128/JVI.64.5.2448-2451.1990

E J Wolffe, E Katz, A Weisberg, B Moss, The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus. Journal of Virology. ,vol. 71, pp. 3904- 3915 ,(1997) , 10.1128/JVI.71.5.3904-3915.1997

P L Earl, B Moss, R W Doms, Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. Journal of Virology. ,vol. 65, pp. 2047- 2055 ,(1991) , 10.1128/JVI.65.4.2047-2055.1991

S Chakrabarti, K Brechling, B Moss, Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Molecular and Cellular Biology. ,vol. 5, pp. 3403- 3409 ,(1985) , 10.1128/MCB.5.12.3403

B. El-Ad, Y. Roth, A. Winder, Z. Tochner, T. Lublin-Tennenbaum, E. Katz, T. Schwartz, The Persistence of Neutralizing Antibodies after Revaccination against Smallpox The Journal of Infectious Diseases. ,vol. 161, pp. 446- 448 ,(1990) , 10.1093/INFDIS/161.3.446

Gilles Pialoux, JEAN-LOUIS EXCLER, YVES RIVIÈRE, GUSTAVO GONZALEZ-CANALI, VINCENT FEUILLIE, PIERRE COULAUD, JEAN-CLAUDE GLUCKMAN, THOMAS J MATTHEWS, BERNARD MEIGNIER, MARIE-PAULE KIENY, PASCALE GONNET, ISABELLE DIAZ, CLAUDE MÉRIC, ENZO PAOLETTI, JAMES TARTAGLIA, HERVÉ SALOMON, STANLEY PLOTKIN, AGIS GROUP, 8, L'AGENCE NATIONALE DE RECHERCHE SUR LE SIDA, A Prime-Boost Approach to HIV Preventive Vaccine Using a Recombinant Canarypox Virus Expressing Glycoprotein 160 (MN) followed by a Recombinant Glycoprotein 160 (MN/LAI) AIDS Research and Human Retroviruses. ,vol. 11, pp. 373- 381 ,(1995) , 10.1089/AID.1995.11.373

R Blasco, B Moss, Role of cell-associated enveloped vaccinia virus in cell-to-cell spread Journal of Virology. ,vol. 66, pp. 4170- 4179 ,(1992) , 10.1128/JVI.66.7.4170-4179.1992

E Katz, E J Wolffe, B Moss, The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions. Journal of Virology. ,vol. 71, pp. 3178- 3187 ,(1997) , 10.1128/JVI.71.4.3178-3187.1997